Joint Seminar by the Japan Association of Medical Management Consultants (Aomori, Iwate, Akita) | Keisuke Komura – mbp

News Highlights

At a joint seminar hosted by the Japan Association of Medical Management Consultants (Aomori, Iwate, Akita), Keisuke Komura emphasized the importance of third-party succession in medical institution business succession. He recommended early consideration starting around age 60 and utilizing specialized advisors for medical M&A as alternatives to closure or business cessation when there is no successor. Lack of Successor

Perspective from M&A Medical Editorial Department

This joint seminar, held in Aomori, Iwate, and Akita – regions where the balance between medical resource concentration and maintaining regional healthcare is particularly critical – offers valuable insights. Mr. Komura’s point about “preparing over a 5-10 year span starting around age 60” suggests the necessity of strategic M&A and business succession, looking beyond just finding a successor to ensure the continuity of regional medical care. Especially as the issue of successor absence becomes more severe, considering third-party succession is indispensable to avoid closure or business cessation and maintain the healthcare provision system in the region. Utilizing advisors specialized in medical institutions will be key to smoothly achieving succession by comprehensively addressing complex factors such as legal, financial, and regional healthcare collaboration.

Key Discussion Points from This News

• Regional challenges in business succession in the Tohoku region (Aomori, Iwate, Akita) and the necessity of third-party succession
• The specifics of a 10-year business succession plan that directors/chairpersons should begin around age 60
• Expanding options by utilizing specialized medical M&A advisors to avoid closure or business cessation
• The importance of establishing strategic business succession schemes to ensure the continuity of regional healthcare

Practical Questions Arising from This News

• What are the criteria for determining if third-party succession is a realistic option, considering the specific regional characteristics of one’s own institution?
• If starting business succession preparations around age 60, what specific steps should be taken?
• When engaging a specialized medical M&A advisor, what factors should be prioritized in their selection?

If You Feel “Should I Consult Too?”

It is time to consider consultation if your institution is facing a situation where successor absence is becoming severe in your location (Aomori, Iwate, Akita, etc.), forcing you to consider closure or business cessation, or if you, as the director/chairperson, are approaching age 60 and have vague concerns about future business succession. Especially if you prioritize the continuity of regional healthcare, it is important to collaborate with experts early on to explore the possibilities of third-party succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as an M&A support institution certified by the Small and Medium Enterprise Agency. Consultations are accepted with strict confidentiality. Free consultation here